TY - JOUR
T1 - Predictors of Cognitive Change in Parkinson Disease
T2 - A 2-year Follow-up Study
AU - Gasca-Salas, Carmen
AU - Duff-Canning, Sarah
AU - McArthur, Eric
AU - Armstrong, Melissa J.
AU - Fox, Susan
AU - Meaney, Christopher A.
AU - Tang-Wai, David F.
AU - Gill, David
AU - Eslinger, Paul J.
AU - Zadikoff, Cindy
AU - Marshall, Fred J.
AU - Mapstone, Mark
AU - Chou, Kelvin L.
AU - Persad, Carol
AU - Litvan, Irene
AU - Mast, Benjamin T.
AU - Gerstenecker, Adam T.
AU - Weintraub, Sandra
AU - Marras, Connie
N1 - Publisher Copyright:
© 2023 Lippincott Williams and Wilkins. All rights reserved.
PY - 2023/10/1
Y1 - 2023/10/1
N2 - Background: Mild cognitive impairment is common in Parkinson disease (PD-MCI). However, instability in this clinical diagnosis and variability in rates of progression to dementia raises questions regarding its utility for longitudinal tracking and prediction of cognitive change in PD. We examined baseline neuropsychological test and cognitive diagnosis predictors of cognitive change in PD. Methods: Persons with PD, without dementia PD (N=138) underwent comprehensive neuropsychological assessment at baseline and were followed up to 2 years. Level II Movement Disorder Society criteria for PD-MCI and PD dementia (PDD) were applied annually. Composite global and domain cognitive z-scores were calculated based on a 10-test neuropsychological battery. Results: Baseline diagnosis of PD-MCI was not associated with a change in global cognitive z-scores. Lower baseline attention and higher executive domain z-scores were associated with greater global cognitive z-score worsening regardless of cognitive diagnosis. Worse baseline domain z-scores in the attention and language domains were associated with progression to MCI or PDD, whereas higher baseline scores in all cognitive domains except executive function were associated with clinical and psychometric reversion to "normal" cognition. Conclusions: Lower scores on cognitive tests of attention were predictive of worse global cognition over 2 years of follow-up in PD, and lower baseline attention and language scores were associated with progression to MCI or PDD. However, PD-MCI diagnosis per se was not predictive of cognitive decline over 2 years. The association between higher executive domain z-scores and greater global cognitive worsening is probably a spurious result.
AB - Background: Mild cognitive impairment is common in Parkinson disease (PD-MCI). However, instability in this clinical diagnosis and variability in rates of progression to dementia raises questions regarding its utility for longitudinal tracking and prediction of cognitive change in PD. We examined baseline neuropsychological test and cognitive diagnosis predictors of cognitive change in PD. Methods: Persons with PD, without dementia PD (N=138) underwent comprehensive neuropsychological assessment at baseline and were followed up to 2 years. Level II Movement Disorder Society criteria for PD-MCI and PD dementia (PDD) were applied annually. Composite global and domain cognitive z-scores were calculated based on a 10-test neuropsychological battery. Results: Baseline diagnosis of PD-MCI was not associated with a change in global cognitive z-scores. Lower baseline attention and higher executive domain z-scores were associated with greater global cognitive z-score worsening regardless of cognitive diagnosis. Worse baseline domain z-scores in the attention and language domains were associated with progression to MCI or PDD, whereas higher baseline scores in all cognitive domains except executive function were associated with clinical and psychometric reversion to "normal" cognition. Conclusions: Lower scores on cognitive tests of attention were predictive of worse global cognition over 2 years of follow-up in PD, and lower baseline attention and language scores were associated with progression to MCI or PDD. However, PD-MCI diagnosis per se was not predictive of cognitive decline over 2 years. The association between higher executive domain z-scores and greater global cognitive worsening is probably a spurious result.
UR - http://www.scopus.com/inward/record.url?scp=85178499597&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85178499597&partnerID=8YFLogxK
U2 - 10.1097/WAD.0000000000000576
DO - 10.1097/WAD.0000000000000576
M3 - Article
C2 - 37615480
AN - SCOPUS:85178499597
SN - 0893-0341
VL - 37
SP - 335
EP - 342
JO - Alzheimer Disease and Associated Disorders
JF - Alzheimer Disease and Associated Disorders
IS - 4
ER -